CRPS Medications on a Pharmacy Lien: High-Value Case Evidence Guide

James Wong — Founder & Pharmacist, LienScripts | March 26, 2026 | 8 min read

Complex Regional Pain Syndrome (CRPS) requires a multi-drug regimen spanning neuropathic pain, anti-inflammatory, vascular, and psychological medications — often for years. The extensive pharmacy record is cornerstone evidence for these high-value personal injury cases.

CRPS Medications on a Pharmacy Lien: High-Value Case Evidence Guide

Complex Regional Pain Syndrome (CRPS) is a chronic neuropathic pain condition that develops after trauma — including fractures, crush injuries, and surgical procedures — and requires a multi-drug treatment regimen spanning neuropathic pain agents, anti-inflammatory medications, vascular modulators, and psychological support medications. CRPS medication management typically continues for one to five years or longer, creating one of the most extensive pharmacy lien records in personal injury practice and some of the strongest objective evidence for high-value demand packages.

• CRPS affects 5-26 per 100,000 person-years following trauma, with fractures being the most common precipitating event (Bruehl, 2015, Lancet Neurology; PMID: 25575710)
• The multi-drug CRPS regimen typically includes 5 to 8 concurrent medications across neuropathic pain, anti-inflammatory, vascular, and psychological categories
• Treatment duration averages 1 to 5 years, with some patients requiring lifelong medication management
• The extensive, long-duration medication profile is itself diagnostic evidence — physicians do not prescribe 5+ medications for 2+ years for a fabricated condition
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that presents the CRPS medication timeline as a pharmacist-signed clinical summary documenting the multi-system nature and chronicity of the condition

Why CRPS Cases Carry High Settlement Value

CRPS is recognized by pain medicine specialists as one of the most severe chronic pain conditions. The McGill Pain Scale rates CRPS pain above amputation, cancer pain, and childbirth. For attorneys, the medication profile provides objective documentation of this severity. According to James Wong, PharmD, founder of LienScripts, "A CRPS pharmacy record is unlike any other personal injury medication file. When I see a patient on gabapentin, nifedipine, amitriptyline, a topical compound, an SSRI, and a sleep agent — all prescribed continuously for 18 months — that medication breadth is itself proof that the condition is real, severe, and medically validated."

[!KEY] CRPS medication profiles are among the most extensive in personal injury practice — 5 to 8 concurrent medications across multiple drug classes, continuing for years. This breadth and duration of pharmacological treatment is powerful objective evidence that the condition is genuine, severe, and requires ongoing medical management.

Neuropathic Pain Medications: The Foundation

Neuropathic pain is the hallmark symptom of CRPS. The gabapentinoid and antidepressant agents prescribed for this pain document nerve system dysfunction.

Gabapentinoids (first-line):

• Gabapentin (Neurontin) — typically initiated at 300 mg daily and titrated to 1800-3600 mg daily in divided doses. The titration schedule — visible in the pharmacy record as increasing quantities over weeks — documents progressive dose optimization for refractory pain.
• Pregabalin (Lyrica) — FDA-approved for neuropathic pain (FDA label, NDA 021446), dosed at 150-600 mg daily. Pregabalin's FDA indication provides additional clinical credibility for the neuropathic pain diagnosis.

Antidepressants at analgesic doses:

• Amitriptyline or nortriptyline — tricyclic antidepressants at 25-100 mg nightly for neuropathic pain. These are prescribed at analgesic doses, not psychiatric doses — a distinction important for the record.
• Duloxetine (Cymbalta) — an SNRI with FDA approval for chronic musculoskeletal pain and diabetic neuropathy. Increasingly used in CRPS for its dual pain mechanism. A 2018 systematic review in Pain Medicine found duloxetine effective for neuropathic pain conditions (PMID: 29025157).

Topical agents:

• Compounded topical creams — ketamine/gabapentin/lidocaine/amitriptyline combinations applied directly to the affected limb. These specialty compounds document the severity of the localized pain and the need for multi-agent topical intervention.
• Lidocaine patches — applied to the affected area for localized anesthetic effect.
• Capsaicin cream (high-concentration) — desensitizes peripheral nerve fibers through substance P depletion.

[!TIP] In CRPS cases, track the gabapentinoid dose titration over time. A patient who started at gabapentin 300 mg daily and required escalation to 3600 mg daily has documented evidence of progressive pain refractory to standard dosing — each dose increase is a physician's clinical judgment that the prior dose was inadequate.

Anti-Inflammatory and Vascular Medications

CRPS involves neurogenic inflammation and vascular dysfunction (vasoconstriction/vasodilation, edema, skin temperature changes). Medications targeting these mechanisms document the multi-system nature of the condition.

Anti-inflammatory agents:

• Prednisone (short courses) — oral corticosteroid bursts for acute CRPS flares. Multiple documented steroid bursts over time prove the condition has an active inflammatory component that recurs.
• Bisphosphonates (alendronate, pamidronate) — traditionally used for osteoporosis, bisphosphonates have shown efficacy in CRPS by reducing bone turnover and inflammatory mediators. A 2013 Cochrane review found moderate evidence supporting bisphosphonate use in CRPS (PMID: 23633316). Their prescription documents that the CRPS has caused bone-level changes (regional osteoporosis).
• NSAIDs — celecoxib or naproxen as baseline anti-inflammatory therapy.

Vascular modulators:

• Nifedipine — a calcium channel blocker used to improve blood flow in the affected limb. Its prescription documents vascular dysfunction — temperature changes, color changes — associated with CRPS.
• Prazosin — an alpha-blocker used for CRPS-related sympathetic nervous system dysfunction, particularly when cold-type CRPS is present.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "When I see nifedipine prescribed alongside gabapentin and amitriptyline for a CRPS patient, the medication list itself tells the diagnostic story. You have nerve pain medications, a vascular agent, and an analgesic antidepressant — three separate body systems being treated pharmacologically. That is documentation of multi-system disease."

[!KEY] Vascular medications (nifedipine, prazosin) and bisphosphonates prescribed for CRPS document dimensions of the condition beyond pain — vascular dysfunction and bone changes. These additional medication categories strengthen the case by proving multi-system involvement that simple pain exaggeration cannot explain.

Psychological and Sleep Medications

CRPS is associated with significant psychological comorbidity — depression, anxiety, sleep disruption, and in some cases PTSD from the inciting trauma. Medications for these conditions, when initiated after the CRPS diagnosis, document the psychological impact of chronic severe pain.

• Sertraline or escitalopram — SSRIs for CRPS-related depression and anxiety
• Trazodone — for sleep disruption caused by chronic pain and medication side effects
• Hydroxyzine or gabapentin (bedtime dosing) — for anxiety and sleep when conventional sleep agents are insufficient
• Clonidine — used in some CRPS protocols for both sympathetic nervous system modulation and sleep/anxiety support

Duration and the Pharmacy Lien Advantage

CRPS medication management is measured in years, not months. A pharmacy lien through LienScripts provides uninterrupted medication access throughout this extended treatment, ensuring:

• No cost-driven treatment gaps — patients never skip fills due to financial barriers
• Continuous documentation — every fill, dose change, and medication addition across the full treatment duration is captured
• Multi-year evidence base — the pharmacy record spanning 12 to 36+ months provides a quantitative foundation for life care plan projections

The LienScripts MERIT (Medication Evaluation & Rationale for Injury Treatment) report for CRPS cases organizes the medication profile by body system — neuropathic pain, inflammatory, vascular, psychological — highlighting the multi-system nature of the condition in a format designed for demand packages and mediation presentations.

Frequently Asked Questions